Arrhythmogenic Cardiomyopathy: Diagnosis, Evolution, Risk Stratification and Pediatric Population—Where Are We? †

Arrhythmogenic cardiomyopathy (ACM) is a cardiomyopathy characterized by the occurrence of a high risk of life-threatening ventricular arrhythmias and sudden cardiac death even at presentation. Diagnosis, evolution and outcomes in adults have been extensively reported, but little data in pediatric p...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicenia, Marianna, Drago, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024428/
https://www.ncbi.nlm.nih.gov/pubmed/35448074
http://dx.doi.org/10.3390/jcdd9040098
_version_ 1784690585295126528
author Cicenia, Marianna
Drago, Fabrizio
author_facet Cicenia, Marianna
Drago, Fabrizio
author_sort Cicenia, Marianna
collection PubMed
description Arrhythmogenic cardiomyopathy (ACM) is a cardiomyopathy characterized by the occurrence of a high risk of life-threatening ventricular arrhythmias and sudden cardiac death even at presentation. Diagnosis, evolution and outcomes in adults have been extensively reported, but little data in pediatric population are available. Risk stratification in this particular setting is still a matter of debate and new risk factors are needed in a model of an ever more “individualized medicine”.
format Online
Article
Text
id pubmed-9024428
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90244282022-04-23 Arrhythmogenic Cardiomyopathy: Diagnosis, Evolution, Risk Stratification and Pediatric Population—Where Are We? † Cicenia, Marianna Drago, Fabrizio J Cardiovasc Dev Dis Review Arrhythmogenic cardiomyopathy (ACM) is a cardiomyopathy characterized by the occurrence of a high risk of life-threatening ventricular arrhythmias and sudden cardiac death even at presentation. Diagnosis, evolution and outcomes in adults have been extensively reported, but little data in pediatric population are available. Risk stratification in this particular setting is still a matter of debate and new risk factors are needed in a model of an ever more “individualized medicine”. MDPI 2022-03-27 /pmc/articles/PMC9024428/ /pubmed/35448074 http://dx.doi.org/10.3390/jcdd9040098 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Cicenia, Marianna
Drago, Fabrizio
Arrhythmogenic Cardiomyopathy: Diagnosis, Evolution, Risk Stratification and Pediatric Population—Where Are We? †
title Arrhythmogenic Cardiomyopathy: Diagnosis, Evolution, Risk Stratification and Pediatric Population—Where Are We? †
title_full Arrhythmogenic Cardiomyopathy: Diagnosis, Evolution, Risk Stratification and Pediatric Population—Where Are We? †
title_fullStr Arrhythmogenic Cardiomyopathy: Diagnosis, Evolution, Risk Stratification and Pediatric Population—Where Are We? †
title_full_unstemmed Arrhythmogenic Cardiomyopathy: Diagnosis, Evolution, Risk Stratification and Pediatric Population—Where Are We? †
title_short Arrhythmogenic Cardiomyopathy: Diagnosis, Evolution, Risk Stratification and Pediatric Population—Where Are We? †
title_sort arrhythmogenic cardiomyopathy: diagnosis, evolution, risk stratification and pediatric population—where are we? †
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024428/
https://www.ncbi.nlm.nih.gov/pubmed/35448074
http://dx.doi.org/10.3390/jcdd9040098
work_keys_str_mv AT ciceniamarianna arrhythmogeniccardiomyopathydiagnosisevolutionriskstratificationandpediatricpopulationwherearewe
AT dragofabrizio arrhythmogeniccardiomyopathydiagnosisevolutionriskstratificationandpediatricpopulationwherearewe

Ejemplares similares